biotech · Recurrent Plasma Cell Myeloma · Anal Cancer Metastatic · ONCY
Oncolytics Biotech
ONCOLYTICS BIOTECH INC
Oncolytics Biotech patent portfolio — 66 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.
Company details
- Status
- Public
- HQ
- 4350 Executive Dr, 325, San Diego, California 92121, US
- Founded
- 1998
- Employees
- 46
- Programs
- 23
- Drugs
- 14
- Patents
- 66
Oncolytics Biotech patents
66 pharmaceutical patents indexed for Oncolytics Biotech. 9 expire within 24 months.
Oncolytics Biotech has 66 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 9 expire within 24 months — use filters for patent-cliff planning.
Patent portfolio
-
US 7052832
Methods for the treatment of cellular proliferative disorders
granted -
US 7049127
Method of producing infectious reovirus
expired -
US 7014847
Methods for preventing reovirus recognition for the treatment of cellular proliferative disorders
expired -
US 6994858
Reovirus clearance of ras-mediated neoplastic cells from mixed cellular compositions
expired -
US 6811775
Reovirus for the treatment of cellular proliferative disorders
expired -
US 6808916
Method of extracting virus from cell culture
expired -
US 6703232
Method of producing infectious reovirus
expired -
US 6649157
Viruses for the treatment of cellular proliferative disorders
expired -
US 6596268
Viruses for the treatment of cellular proliferative disorders
expired -
US 6576234
Reovirus for the treatment of neoplasia
expired -
US 6565831
Methods for preventing reovirus recognition for the treatment of cellular proliferative disorders
expired -
US 6528305
Method of producing infectious reovirus
expired -
US 6455038
Reovirus for the treatment of cellular proliferative disorders
expired -
US 6344195
Reovirus for the treatment of neoplasia
expired -
US 6312736
Herbal composition to relieve pain
expired -
US 6261555
Reovirus for the treatment of neoplasia
expired -
US 6136307
Reovirus for the treatment of cellular proliferative disorders
expired -
US 6110461
Reovirus for the treatment of neoplasia
expired
Frequently asked questions
How many patents does Oncolytics Biotech have?
66 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do Oncolytics Biotech patents expire?
9 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.